Catalent Pharma Solutions, Inc. (CTLT)

Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)

63.48

0.00 (0.00%)

Inactive · Last trade price on Dec 17, 2024

Catalent Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	2004 - 2008
Period Ending	Dec '24 Dec 17, 2024	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010	Jun '09 Jun 30, 2009	2004 - 2008
Debt / Equity Ratio	-6.82	-6.56	-7.72	-11.38	-8.82	29.51	Upgrade
Debt / EBITDA Ratio	7.05	7.08	7.62	7.25	8.06	9.20	Upgrade
Debt / FCF Ratio	56.16	177.08	-	192.65	14.24	-	Upgrade
Asset Turnover	0.59	0.58	0.57	0.55	0.51	0.46	Upgrade
Inventory Turnover	7.64	9.22	8.36	7.11	6.07	5.58	Upgrade
Quick Ratio	0.97	1.13	1.09	1.21	1.05	0.82	Upgrade
Current Ratio	1.52	1.65	1.60	1.97	1.79	1.57	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-75.14%	Upgrade
Return on Assets (ROA)	4.84%	4.60%	4.72%	4.81%	3.64%	2.29%	Upgrade
Return on Capital (ROIC)	6.49%	6.15%	6.21%	6.30%	4.73%	2.86%	Upgrade
Return on Capital Employed (ROCE)	8.80%	8.60%	8.40%	8.70%	7.30%	4.60%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q